CTOs on the Move

HCI Hospital TV

www.hci-tv.com

 
HCI Hospital TV is a Loveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.hci-tv.com
  • 113 Commerce Dr
    Loveland, OH USA 45140
  • Phone: 800.783.8105

Executives

Name Title Contact Details

Similar Companies

Las Vegas RAdiology

Las Vegas RAdiology is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Focus Health

Focus Health is a Kearney, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Care Angel

Care Angel is the industry leader in automation and exponentially scalable solutions for continuous engagement, management, surveillance, triage, navigation and care of millions. ANGEL, the world`s first voice-enabled, AI-Nurse Assistant comes to life through the company`s award-winning SmartCare Platform. ANGEL enables the most effective, efficient and scalable way to engage, monitor and manage large, at-risk populations with complex and chronic conditions at the lowest cost, starting with a simple phone call or text-based care conversation. Care Angel`s AI solutions give care teams the ability to conversationally collect accurate patient data, consistently and continuously, receiving regular updates on vitals and well-being to inform and manage real-time interventions and avoid missed care opportunities.

UltraRAD Corp

UltraRAD Corp is a West Berlin, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.